A detailed history of Avantax Advisory Services, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 8,632 shares of EW stock, worth $584,904. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,632
Previous 20,709 58.32%
Holding current value
$584,904
Previous $1.91 Million 70.24%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $720,996 - $1.13 Million
-12,077 Reduced 58.32%
8,632 $569,000
Q2 2024

Aug 09, 2024

BUY
$84.3 - $94.31 $1.17 Million - $1.3 Million
13,822 Added 200.7%
20,709 $1.91 Million
Q1 2024

May 08, 2024

BUY
$72.54 - $95.56 $19,730 - $25,992
272 Added 4.11%
6,887 $658,000
Q4 2023

Feb 07, 2024

BUY
$61.71 - $77.76 $2,838 - $3,576
46 Added 0.7%
6,615 $504,000
Q3 2023

Nov 07, 2023

SELL
$69.28 - $93.38 $78,494 - $105,799
-1,133 Reduced 14.71%
6,569 $455,000
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $2,930 - $3,395
-36 Reduced 0.47%
7,702 $726,000
Q1 2023

Apr 28, 2023

BUY
$74.26 - $84.51 $3,713 - $4,225
50 Added 0.65%
7,738 $640,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $111,192 - $142,352
1,628 Added 26.86%
7,688 $573,000
Q3 2022

Nov 01, 2022

SELL
$82.37 - $107.29 $49,422 - $64,374
-600 Reduced 9.01%
6,060 $501,000
Q2 2022

Aug 02, 2022

BUY
$86.5 - $128.27 $61,155 - $90,686
707 Added 11.88%
6,660 $633,000
Q1 2022

Apr 27, 2022

BUY
$101.96 - $128.34 $34,462 - $43,378
338 Added 6.02%
5,953 $699,000
Q4 2021

Jan 24, 2022

SELL
$106.37 - $130.68 $65,736 - $80,760
-618 Reduced 9.91%
5,615 $727,000
Q3 2021

Oct 21, 2021

SELL
$102.91 - $122.75 $69,155 - $82,488
-672 Reduced 9.73%
6,233 $702,000
Q2 2021

Jul 29, 2021

BUY
$83.84 - $104.76 $125,843 - $157,244
1,501 Added 27.78%
6,905 $717,000
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $18,568 - $21,398
236 Added 4.57%
5,404 $457,000
Q4 2020

Jan 22, 2021

SELL
$71.69 - $91.23 $475,304 - $604,854
-6,630 Reduced 56.2%
5,168 $473,000
Q3 2020

Oct 14, 2020

BUY
$67.19 - $87.44 $423,431 - $551,046
6,302 Added 114.67%
11,798 $944,000
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $229,239 - $306,568
3,984 Added 263.49%
5,496 $372,000
Q1 2020

Apr 30, 2020

BUY
$52.41 - $81.0 $79,243 - $122,472
1,512 New
1,512 $284,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.